Mkts

HeartSciences Inc.

NASDAQ: HSCS
$2.71-0.12 (-4.24%)
As of Nov 9, 4:00 PM ET

Key statistics

Day range
2.602.96
52-week range
1.635.25
Today
Open2.78
Previous close2.71
Volume—
Valuation
Market cap13.47M
P/E ratio—
EPS (TTM)-3.21
Income & risk
Dividend / yield—
Beta1.82
Avg volume133.6K
Discussion

HSCS News

Stories mentioning HSCS from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Jan 31Q4 '25Oct 31Q3 '25Jul 31Q2 '25Apr 30Q1 '25Jan 31Q4 '24Oct 31Q3 '24Jul 31Q2 '24Apr 30
Income Statement
Revenue0.002.002.000.00
Cost of Goods Sold0.001.001.000.00
Gross Profit0.001.001.002.000.000.000.001.00
Operating Expenses
Research & Development639.00727.00997.00929.001,0331,1991,2251,046
Sales General & Admin1,2901,348878.00994.001,338786.00851.00834.00
Total Operating Expenses1,9292,0751,8751,9232,3711,9852,0761,879
Operating Income (Loss)(1,929)(2,073)(1,874)(1,921)(2,371)(1,985)(2,076)(1,880)
Interest Income
Interest Expense22.00
Other Expense5.0015.00
Pretax Income
Tax Provision
Net Income (Loss)(1,985)(2,351)(2,055)(2,094)(2,536)(2,083)(2,052)(1,846)
Earnings Per Share (Basic)(0.63)(0.85)(1.58)(2.23)(2.57)(2.27)(2.64)(5.23)
Earnings Per Share (Diluted)(0.85)(1.58)(2.23)(2.57)(2.27)(2.64)(5.23)
Weighted Average Shares Outstanding (Basic)3,1622,7801,304938.00986.00917.00778.00353.00
Weighted Average Shares Outstanding (Diluted)2,7801,304938.00986.00917.00778.00353.00

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About HSCS

HeartSciences Inc. (NASDAQ: HSCS) is a stock listed on the Nasdaq Stock Market under the ticker symbol HSCS. It last traded at $2.71 (Nov 9, 2026, 4:00 PM ET), down 4.2% on the day. That gives HeartSciences a market capitalisation of $13.5M.

Over the past 52 weeks HSCS has traded between $1.63 and $5.25.

Revenue for the quarter ended Jan 31, 2026 was $0; a net loss of $2.0M.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Jan 31, 2026$0-$2.0M—
Oct 31, 2025$2.0K-$2.4M-117550.0%
Jul 31, 2025$2.0K-$2.1M-102750.0%
Apr 30, 2025—-$2.1M—

From HeartSciences’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…